Glutamate And Schizophrenia Beyond The Dopamine Hypothesis, We also review the NMDA .

Glutamate And Schizophrenia Beyond The Dopamine Hypothesis, Both were initially based on indirect  Автор: A Hasan · 2014 · Цитируется: 31 — To sum up, one could note that the glutamate hypothesis of schizophrenia is now well-established. With continued advancements, glutamate modulation has the potential to transform schizophrenia treatment, particularly for cognitive and  The glutamate and dopamine hypotheses are leading theories of the pathoaetiology of schizophrenia. We also review the NMDA  Автор: O Howes · 2015 · Цитируется: 1132 — The glutamate and dopamine hypotheses are leading theories of the pathoaetiology of schizophrenia. Автор: DC Javitt · Цитируется: 781 — To date, the most widely considered neurochemical hypothesis of schizophrenia is the dopamine hypothesis, which postulates that symptoms of schizophrenia  Автор: P Seeman · 2009 · Цитируется: 101 — Hence, the clinical antipsychotic action of a glutamate agonist may depend on its ability to interfere with DA neurotransmission by its DA partial agonism. There is growing evidence that two neurotransmitters - dopamine and glutamate - are abnormal in people with psychotic illness, including  Directly and Indirectly Targeting the Glycine Modulatory Site to Modulate NMDA Receptor Function to Address Unmet Medical Needs of Patients With Schizophrenia. The development of glutamatergic antipsychotics is still in  Автор: AO Kruse · 2022 · Цитируется: 216 — In schizophrenia there have been over 130 studies published examining group differences in glutamate, its metabolite glutamine (Gln) and  Автор: HH Kornhuber · 1984 · Цитируется: 51 — In addition to the dopamine hypothesis, a glutamate hypothesis has been recently discussed in the biochemical theories on the cause of schizophrenia. We also review the NMDA  As compared to dopaminergic agents, NMDA antagonists induce negative and cognitive symptoms of schizophrenia, as well as positive symptoms. The NMDA receptor hypofunction hypothesis proposes that  Автор: JM Stone · 2007 · Цитируется: 569 — In this review, we study the evidence for dopaminergic dysfunction in schizophrenia, drawing data from neurochemical imaging studies. Treatment studies  Автор: AO Kruse · 2022 · Цитируется: 216 — In schizophrenia there have been over 130 studies published examining group differences in glutamate, its metabolite glutamine (Gln) and combinations of Glu and  Автор: RA McCutcheon · 2020 · Цитируется: 808 — Glutamate and dopamine systems play distinct roles in terms of neuronal signalling, yet both have been proposed to contribute significantly  New approaches for treating all schizophrenia symptoms by modulating dopamine and glutamate in non-traditional ways. The glutamate hypothesis of schizophrenia, proposed over two decades ago, originated following the observation that administration of drugs that block NMDA  Автор: W Hu · 2014 · Цитируется: 409 — A number of studies have indicated that antagonists of the N-methyl-d-aspartate (NMDA) subtypes of glutamate receptors can cause schizophrenia-like symptoms  Thus, a new hypothesis was formed, called the glutamate hypothesis, which postulates that schizophrenia results from the hypofunction of the glutamatergic  Автор: B Moghaddam · 2012 · Цитируется: 1416 — Glutamatergic theories of schizophrenia are based on the ability of N-methyl-D-aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as . Disturbances in glutamate transmission and NMDA receptor hypofunction are associated with schizophrenia. Both were initially based on indirect  Glutamate and dopamine systems play distinct roles in terms of neuronal signalling, yet both have been proposed to contribute significantly  Автор: M Laruelle · 2003 · Цитируется: 662 — In conclusion, it is proposed that schizophrenia is associated with strongly interconnected abnormalities of GLU and DA transmission: NMDA hypofunction in the  In conclusion, it is proposed that schizophrenia is associated with strongly interconnected abnormalities of GLU and DA transmission: NMDA  In this review, we study the evidence for dopaminergic dysfunction in schizophrenia, drawing data from neurochemical imaging studies. avc01bc, q3fs, ue, wqz, wa4uik, wqv, mmfwvn, hpr5e, rk, foot,